NEW YORK, July 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment-of-Eye-Care-Medication-Brands.html

This study encompasses feedback provided by U.S. physicians on aspects of ophthalmology drug treatment, enabling interested stakeholders to gain insight into current and future trends. Frost & Sullivan conducted a web-based survey of 152 U.S. Ophthalmologists in November 2009. Of these respondents, 48 percent are in single-specialty group practice, 38 percent are in solo practice, and the rest are in multi-specialty group practice or in hospital-based clinics. 

Please note that Table of Contents numbering has been standardized and may not match numbering within the publication.

1: Research Objectives, Method Details, and Segmentation

1.1: Research Objectives and Method Details

Table 1: Research Objectives and Method Details

1.2: Segmentation

2: Executive Summary

2.1: Patient Compliance to Eye Care Medications

2.2: Factors Impacting Eye Care Medication Prescriptions

2.3: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

Table 2: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

3: Patient Compliance with Eye Care Medications

3.1: Assessment of Patient Compliance

3.2: Analyst Comments

3.3: Average Number of Medications Taken by Glaucoma Patients

4: Factors Impacting Prescriptions of Eye Care Medications

4.1: Eye Care Medications: Most Important Features

4.2: Other Factors Correlateda/ with Efficacy, the Most Important Factor for Prescribing Eye Care Medications

4.3: Patients' Involvement in Eye Care Medication Selection Process

5: Preferences for Glaucoma Medications

5.1: Prostaglandin Analogues for Glaucoma

5.1.1: Primary Brand Use and Brand Reputation

5.1.2: Brand Loyalty

5.2: Beta Blockers for Glaucoma

5.2.1: Primary Brand Use and Brand Reputation

5.2.2: Brand Loyalty

5.3: Combination Therapies for Glaucoma

5.3.1: Primary Brand Use and Brand Reputation

5.3.2: Brand Loyalty

5.4: Carbonic Anhydrase Inhibitors for Glaucoma

5.4.1: Primary Brand Use and Brand Reputation

5.4.2: Brand Loyalty

5.5: Alpha Adrenergic Agonists for Glaucoma

5.5.1: Primary Brand Use and Brand Reputation

6: Preferences for Other Eye Disease Medications

6.1: Age-Related Macular Degeneration Medications

6.1.1: Primary Brand Use and Brand Reputation

6.1.2: Brand Loyalty

6.1.3: Lucentis Versus Avastin

6.2: Allergic Conjunctivitis Medications

6.2.1: Primary Brand Use and Brand Reputation

6.2.2: Brand Loyalty

6.3: NSAID Medications

6.3.1: Primary Brand Use and Brand Reputation

6.3.2: Brand Loyalty

7: Appendices

7.1: Preferences for Glaucoma Medications

7.1.1: Prostaglandin Analogues for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.2: Beta Blockers for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.3: Combination Therapies for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.4: Carbonic Anhydrase Inhibitors for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.2: Preferences for Other Eye Disease Medications

7.2.1: Age-Related Macular Degeneration Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.2: Allergic Conjunctivitis Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.3: NSAID Medications: Reasons for Top Ranking - Sample of Verbatim Comments

To order this report:

Drug and Medication Industry:

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com